½ðÄê»á¡¤(jinnianhui)½ð×ÖÕÐÅÆ³ÏÐÅÖÁÉÏ-Gold Annual Meeting

»¶Ó­À´µ½ÉϺ£Í¨Îµ£¡

021-54845833/15800441009

Æ·Öʱ£Ö¤ ¡¤ ͨεÊÔ¼Á

µ±Ç°Î»ÖÃ: Ê×Ò³ > ¿ÆÑвúÆ· > ¿ÆÑп¹Ìå > Ò»¿¹ > Íÿ¹NAA10¶à¿Ë¡¿¹Ìå

²úÆ·ÖÐÐÄ

×îвúÆ·

  • Íÿ¹NAA10¶à¿Ë¡¿¹Ìå

    ¹æ¸ñ£º
    ¼Û¸ñ£º£¤
    • Æ·ÅÆ : ͨεÉúÎï
    • Ŀ¼ºÅ : TW20459
    • Ó¦Óà : ½ö¹©¿ÆÑÐʹÓÃ
    • »õÆÚ : ÏÖ»õ
    • ¹æ¸ñ £º100ul/200ul/25ul
  • ÉÌÆ·ÏêÇé
  • ²Î¿¼ÎÄÏ×
  • ˵Ã÷ÊéÏÂÔØ
  • ÉÌÆ·ÆÀÂÛ0
  • Ïà¹Ø²úÆ·

ÖÐÎÄÃû³Æ£º Íÿ¹NAA10¶à¿Ë¡¿¹Ìå


Ó¢ÎÄÃû³Æ£º Anti-NAA10 rabbit polyclonal antibody


±ð       Ãû£º N(alpha)-acetyltransferase 10, NatA catalytic subunit; TE2; ARD1; NATD; ARD1A; ARD1P; OGDNS; hARD1; DXS707; MCOPS1


Ïà¹ØÀà±ð£º Ò»¿¹


´¢       ´æ£º Àä¶³£¨-20¡æ£©


ËÞ       Ö÷£º Rabbit


¿¹       Ô­£º NAA10


·´Ó¦ÖÖÊô£º Human, Mouse


±ê  ¼Ç  Î Unconjugate


¿Ë¡ÀàÐÍ£º rabbit polyclonal


¼¼Êõ¹æ¸ñ

Background:

N-alpha-acetylation is among the most common post-translational protein modifications in eukaryotic cells. This process involves the transfer of an acetyl group from acetyl-coenzyme A to the alpha-amino group on a nascent polypeptide and is essential for normal cell function. This gene encodes an N-terminal acetyltransferase that functions as the catalytic subunit of the major amino-terminal acetyltransferase A complex. Mutations in this gene are the cause of Ogden syndrome. Alternate splicing results in multiple transcript variants.

Applications:

ELISA, WB, IHC

Name of antibody:

NAA10

Immunogen:

Fusion protein of human NAA10

Full name:

N(alpha)-acetyltransferase 10, NatA catalytic subunit

Synonyms:

TE2; ARD1; NATD; ARD1A; ARD1P; OGDNS; hARD1; DXS707; MCOPS1

SwissProt:

P41227

ELISA Recommended dilution:

5000-10000

IHC positive control:

Human tonsil and Human thyroid cancer

IHC Recommend dilution:

50-300

WB Predicted band size:

26 kDa

WB Positive control:

Hela and 293T cell lysates

WB Recommended dilution:

200-1000











¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿


¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿